Cohen, P. R., Tomson, B. N., Elkin, S. K., Marchlik, E., Carter, J. L., & Kurzrock, R. (2016). Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: Implications for targeted therapeutics. Oncotarget.
Chicago Style aipamenaCohen, Philip R., Brett N. Tomson, Sheryl K. Elkin, Erica Marchlik, Jennifer L. Carter, and Razelle Kurzrock. "Genomic Portfolio of Merkel Cell Carcinoma As Determined By Comprehensive Genomic Profiling: Implications for Targeted Therapeutics." Oncotarget 2016.
MLA aipamenaCohen, Philip R., et al. "Genomic Portfolio of Merkel Cell Carcinoma As Determined By Comprehensive Genomic Profiling: Implications for Targeted Therapeutics." Oncotarget 2016.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.